NIH's R21 grant funds high-risk, early-stage research with potential for breakthroughs in biomedical, behavioral, or clinical fields, excluding clinical trials.
NIH's R21 grant supports early-stage, high-risk clinical trial research with potential for breakthroughs in biomedical, behavioral, or clinical fields.
NIH grant supports focused research projects requiring at least one clinical trial, aligning with the scientific interests of participating NIH Institutes and Centers.
NIH grant supports specific research projects aligned with NIH Institutes' missions, but excludes clinical trials.
NIH's R03 grant supports small, short-term research projects like pilot studies and methodology development, but excludes clinical trials.
Support for innovative research to improve cancer control through behavior modification, screening, and understanding etiologic factors, with the aim of advancing population-based cancer studies.